Ads
related to: takeda pharmaceuticals
Search results
Takeda nabs option to license Alzheimer’s immunotherapies from AC Immune
BioPharma Dive via Yahoo Finance· 6 hours agoThe deal — worth $100 million up front and potentially billions more later on — gives Takeda an...
AC Immunity Shares Soar on Exclusive License Deal with Takeda
Morningstar· 6 hours agoBy Dean Seal Shares of AC Immunity surged after the company signed announced an agreement with Takeda Pharmaceutical for an exclusive option to license ...
Why Is AC Immune (ACIU) Stock Up 45% Today?
InvestorPlace· 5 hours agoIncluded in that earnings report is an operational update that covers a new collaboration agreement with Takeda Pharmaceutical (NYSE:TAK). This has < ...
Takeda stock down 1% as operating profit declines
Investing.com· 5 days agoTakeda Pharmaceutical (TYO: 4502 ) Company Limited (NYSE: TAK ) has surpassed its management guidance for revenue and core earnings per share (EPS) in...
Takeda Pharmaceutical Projects Lower Annual Profit After Quarterly Loss
The Wall Street Journal· 4 days agoHEALTH Takeda Pharmaceutical reported a fourth-quarter loss and forecast a drop in annual net profit...
Takeda profit slumps by half as Japanese drugmaker rebuilds pipeline
WSAU Wausau· 4 days agoTOKYO (Reuters) - Japan's Takeda Pharmaceutical said full-year earnings slumped by more than half as...
Takeda Pharmaceuticals earnings: profits, EPS down over 50% in Q4 financial results | Invezz
Invezz· 4 days agoThe company described it in a press release as “a year of significant loss-of-exclusivity impact”, a...
Takeda Pharmaceutical Co ADR (TAK) Shares Down Despite Recent Market Volatility – News Heater
NewsHeater· 6 days agoThe stock price of Takeda Pharmaceutical Co ADR (NYSE: TAK) has plunged by -0.60 when compared to previous closing price of 13.36, but the company has seen ...
Correction to Takeda Pharmaceutical Earnings Preview on May 8
Morningstar· 4 days agoTakeda Pharmaceutical was expected to post a net loss of 0.2 billion yen ($1.3 million) for the three months ended March 31, according to a poll of analysts ...
Alzheimer’s vaccine licensing deal boosts AC Immune
Market Watch· 5 hours agoThe deal gives Japanese drugmaker Takeda the exclusive option to license global rights to the vaccine, known as ACI-24.060, which is designed to delay or...
